Wholly owned by the state-run large-scaled red sun group corporation, Jiangsu zhongbang pharmacy co. Ltd. Has a total investment of rmb200 million, and takes up a land of 200,000 square meters. It is a hi-tech enterprise mainly developing and producing l-ephedrine serial products, heart and brain blood vessel disease, infection, respiration system, metabolism and incretion, with the technology base of Nanjing red sun engineering technology center and Nanjing red sun biological pharmacy ...